In a recent display of academic and technological prowess, Professor Kim Sung-hoon and his Biomedical Signal Research Team from Asan Medical Center (AMC) have clinched the top spot in the PhysioNet Challenge 2023 held in Atlanta, Georgia, from Oct. 1-4.The competition is organized by PhysioNet, an o
3billion, an AI-powered genetic diagnostics company for rare diseases, has introduced the NovaSeq X, Illumina's next-generation sequencer.The NovaSeq X, succeeding the NovaSeq 6000, provides a substantial enhancement, offering up to 2.5 times the DNA sequencing capacity per run when compared to its
For Vyndamax (tafamidis), a treatment for the rare disease transthyretin amyloid cardiomyopathy (ATTR-CM), to win insurance benefits, its maker, Pfizer Korea, must be more willing to share the risk, experts said last week.They shared this and other views at the insurance session of the 67th autumnal
Genome Insight, a whole genome sequencing (WGS) company located in San Diego, unveiled its groundbreaking research findings in collaboration with Seoul National University Hospital (SNUH) and Asan Medical Center (AMC) at the 2023 NORD (Rare Disease & Orphan Products Breakthrough Summit).During the o
Sillajen said Monday that it has presented a poster on the clinical study of BAL0891, an anticancer drug undergoing phase I clinical trials in the U.S. and Korea, at the 2023 EORTC-NCI-AACR Symposium, which opened in Boston, Mass.The EORTC-NCI-AACR Symposium is an international conference jointly or
Celltrion Healthcare said it has successfully secured a supply contract for Yuflyma, a biosimilar referencing Humira (ingredient: adalimumab), with CarePartners Pharmacy, a leading Specialty Pharmacy chain in the U.S.The contract follows CarePartners Pharmacy's recent listing of Yuflyma on its pharm
Bayer Korea aims to transform the treatment landscape for patients with chronic heart failure with a left ventricular ejection fraction of less than 45 percent with the recent reimbursement of Verquvo (ingredient: vericiguat), the company said Monday.At the press conference celebrating the drug's re
Prestige Biopharma Group said its Kosdaq-listed Prestige Biopharma and Prestige Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), will participate in CPHI Worldwide 2023 in Barcelona, Spain, from Oct. 24-26, one of the world’s largest trade fairs for the phar
GI Innovation said it licensed out GI-301, its allergy treatment candidate, to Maruho, a Japanese pharmaceutical company specializing in dermatology.Under the accord, GI Innovation is eligible for $221 million, including non-refundable upfront payments, development and commercial milestone payments,
Experts in the healthcare sector, ranging from professionals in companies to medical professors, came together in Seoul on Friday to exchange their expertise and envision the future of generative AI in healthcare.Korea Biomedical Review (KBR), along with its sister publication, The Korean Doctors’ W
The government's announcement that it will increase the enrollment quota of medical students by up to 1,000 is rocking the medical community.The medical community has warned that if the government unilaterally increases the number of doctors in the name of "saving essential medical care," it will ha
With the growth of the cell-gene therapy (CGT) market, the contract development and manufacturing organization (CDMO) business targeting such treatments is also growing.However, industry executives express concern about a “mismatch” between domestic CDMOs and CGT developers.Last Wednesday, Ahn Jong-
A lawmaker criticized the incumbent government's stance that a policy to strengthen health insurance coverage under the previous Moon Jae-in administration led to a fiscal crisis, saying it is "deceiving the public."Rep. Kang Eun-mi of the splinter Justice Party, a member of the National Assembly's
The medical community is cautious about adding more doctors, but the political community’s pressure is intense.After the government announced its intention to increase the medical school enrollment quota, politicians demanded that it be allocated to new medical schools.The government has decided to
The government’s loose management of psychotropic medicines, classified as narcotics, was put on the chopping block of the National Assembly’s administrative audit.Lawmakers pointed out that reasons for “medical shopping,” in which people visit 135 medical institutions a year to get sleeping anesthe
GC said it has signed a joint research and development agreement with Immetas Therapeutics, a U.S.-based pharmaceutical firm, related to mRNA therapeutics for autoimmune diseases.Through this joint research, both companies will develop autoimmune disease therapeutics using Immetas' unique platform f
Bayer Korea said it has appointed Lee Jin-a, the current CEO of Bayer Thailand, as its new CEO of Bayer Group in Korea in charge of its pharmaceutical, consumer health, and crop science divisions, effective from Nov. 1.Lee will become the first Korean CEO in Bayer Group’s Korean offshoot history.Acc
The cumulative wage arrears at national university hospitals have exceeded 4.8 billion won ($3.6 million) over the past five years.On Friday, Rep. Moon Jeong-bok of the Democratic Party of Korea, a National Assembly's Education Committee member, released data on wage arrears at 10 national hospitals
The government should expand medical personnel and hospital beds to prepare for the resurge of Covid-19 cases during the coming winter, a lawmaker said Friday."Despite the serious situation where the number of new Covid-19 cases and deaths continue to increase, the numbers of medical personnel and d
Bayer's kidney drug Kerendia (finerenone) has been recognized as adequate for receiving insurance benefits by the Pharmaceutical Reimbursement Evaluation Committee.Kolon Pharma's three-drug inhaler Trimbow (beclometasone/formoterol/glycopyrronium) and Takeda's hemophilia drug Obizur (susoctocog alph